SoCalBio Mast

SoCalBio Weekly Update
Featured SoCalBio Member
 
 NeuroSystec Corporation
 
Led by Dr. Thomas Lobl (photo above), this Valencia-Calif.-based R&D company is focused on the delivery of neurologically-active therapeutic agents using ultraminiature devices ... Learn more
Become a Member of SoCalBio
 
Join well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth.
Become a Member

SoCalBio Finance Resources

 
Looking for seed or venture capital? Seeking an M&A or a private placement? 
Use SoCalBio-affiliated VCs, angele or investment bankers. Click here to see listing. Click here to see listing
Coming in 2009
  
SoCalBio Workshop on Government (SBIR/STTR) Funding
 
January 29, 2009
UCLA Faculty Center 
RSVP Now
 
--------------------------
 
Talent Development and Retention in Challenging Times 
 
February 26, 2009
Irvine Marriott

Recommended Event

January 16-17, 2009
Marriott Los Angeles Airport
 
Increase your visibility to prospective employees (44% of the life science graduates in California come from the CSU!). CSUPERB is actively recruiting industry mentors for the Career Networking Session. Sponsorships are still available. Please contact Susan Baxter (sbaxter@mail.sdsu.edu) to find out how you can get involved... Click here to register online 
Vivarium Amenities Available 
A Santa Clarita-based biotech company has a state -of-the-art Vivarium that is not fully utilized. If you would like to access this facility to conduct research at reasonable rates, please contact SoCalBio at 213-236-4890 for more information."
Executive Global Business Series: Doing Business In China
Jan 26-28, 2009

Rady Center for Executive Development, UC San Diego
San Diego, CA
 
 
In partnership with the School of International Relations and Pacific Studies, learn strategies for sourcing, designing and marketing products, and investing in China.
 
Experience a full traditional Chinese dinner including etiquette and protocol. This course will teach you everything you need to know about doing business in China.
 
Regular Program Fee: $2,150. Early Bird Discount $1,950* (discount ends Dec 31)

Past Weekly Updates
December 15, 2008
Coming Soon

SoCalBio Networking Forum
in Orange County

December 18, 2008, 7:00 am -  9:30 am
 UCI University Club (Irvine, CA)

Making Every Innovation Count:
Monetizing IP Assets

According to the World Research Group, intangible assets comprise 70% or more of corporate asset value today. Nowhere is this truer than in the case of high-end device and certainly biotech companies. But many often fail to properly manage their IP and miss tremendous opportunities to capture revenues and recognize the value of their intangibles. Furthermore, many executives think that monetizing IP is a no-brainer and fail to take the necessary steps to derive most value out of it. This forum seeks to address the above issues and provide some guidance to device and biotech firms about the best strategies to maximize IP valuation, particularly in the current uncertain economic environment.
 
Moderator
  • Kenneth Charhut, President & CEO, Orqis Medical

Speakers

  • Karen Gibbs, Partner, Crowell & Moring
  • Keith A. Newburry, VP, Chief Intellectual Property Counsel, Edwards Lifesciences
  • Amanda Paracuellos, Partner, Crowell & Moring
Thanks to our Sponsors
From the Lab Bench
  • Key Mechanism of Human Lymphomas Identified by USC Researchers
Researchers at the Keck School of Medicine of USC have explained how certain key mutations occur in human lymphomas - a process that has, until now, remained a mystery. The findings of the study, published in the Dec. 12 issue of the journal Cell, will have a significant impact on future study of how human lymphoma occurs... Read more
  • UCLA Researchers Provide Definitive Proof of Where, How Blood Stem Cells Are Created
A research team at led by Luisa Iruela-Arispe (photo right), a professor of molecular, cell and developmental biology and director of the Cancer Cell Biology Program Area at UCLA's Jonsson Comprehensive Cancer Center have proven definitively that blood stem cells are made during mid-gestational embryonic development by endothelial cells, the cells that line the inside of blood vessels. ... Read more
  • Caltech Researchers Get First Look at How Groups of Cells Coordinate Their Movements
Using novel imaging, labeling, and data-analysis techniques, scientists from the California Institute of Technology have been able to visualize, for the first time, large numbers of cells moving en masse during some of the earliest stages of embryonic development. The findings not only provide insight into this stage of development--called gastrulation--but give a more general glimpse at how a living organism choreographs the motions of thousands of cells at one time. Previous research has been generally limited to imaging the movements of single cells.... Read more
Biomedical R&D Funding
  • U.S. Health Research Funding Reached $122 Billion in 2007, But Failed to Grow Relative to Healthcare Costs Overall
Research funding of medical and health research from government and private sources rose in 2007 to reach approximately $122.4 billion, a modest increase from the $116 billion spent the previous year. The 5.5 percent increase barely allowed research to keep pace with the overall rise in healthcare costs, according to a report from Research!America ... Read report
Finance
  • Why Are the IPOs in the ICU? 
Over the last several years, the IPO market in the United States has practically disappeared. While conventional wisdom may say the U.S. IPO market is going through a cyclical downturn, exacerbated by the recent credit crisis, many are beginning to share a view of a new and much darker reality: The market for underwritten IPOs, given its current structure, is closed to most (80 percent) of the companies that need it. In this white paper, Grant Thornton LLP explores the history of the IPO market, what led us to this crisis, and ideas for a new, opt-in stock market capable of reinvigorating the U.S. IPO market.;... Read paper
  • Move Over Big Three. Little Biotech Is Joining You in Seeking Federal Assistance

Biotechnology industry executives ask Congress for a temporary change in the tax law that would let money-losing companies get cash from the government now, in exchange for tax credits they would pledge not to take if they eventually become profitable ... Read more
 Company Headline
Jobs Available
Do you know?


http://www.biosurplus.com

SoCalBio membership provides access to significant discounts on purchases of pre-owned lab equipment from BioSurplus through the SoCalBio Group Purchasing Program. Designed for small and mid-size firms, this program provides SoCalBio members with the following benefits:
  • 5% annual credit or 1% annual cash rebate on equipment purchases or net consignment sales proceeds
  • 10% discount on setup fees for e-Quip enabled services
  • 30-day limited warranty on most purchased equipment
  • Experienced customer service representatives offering knowledgeable and reliable service
For more information, call 213-236-4890 or send e-mail to scbc@socalbio.org
About SoCalBio
SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio
 
Editor: Ahmed A. Enany
Southern California Biomedical Council (SoCalBio)